ESC Premium Access

Alternative treatments for myocardial ischaemia?

Event: ESC CONGRESS 2017
Topic: Ischaemia, experimental studies
Session type: Moderated Posters
Date: 28 August 2017
Time: 15:35 - 16:25

Congress Session

6 presentations in this session

Clinical implications and mechanistic role of eosinophils after reperfused myocardial infarction. Study in patients and swine

Speaker: Mr C. Rios Navarro (Valencia, ES)
Thumbnail

A multicenter trial of extracorporeal cardiac shock wave therapy for refractory angina pectoris - Results from the highly advanced medical treatment in Japan

Speaker: Assistant Professor Y. Kikuchi (Sendai, JP)
Thumbnail

Long term outcome of patients with chronic refractory angina treated by cardiac shockwave therapy.

Speaker: Doctor J. Vainer (Maastricht, NL)
Thumbnail

Sympathetic renal denervation after acute myocardial infarction results in increased myocardial salvage in pigs

Speaker: Doctor L. Pastormerlo (Pisa, IT)
Thumbnail

Short-term blockade of the S100A8/A9 alarmin in the immediate post-myocardial infarction period inhibits acute myocardial inflammation and preserves myocardial repair.

Speaker: Associate Professor A. Schiopu (Malm?, SE)
Thumbnail

Safety and high-grade myocardial uptake of Whartons Jelly Plurioptent Stem Cells transcoronary transfer in acute myocardial infarction in man

Speaker: Professor P. Musialek (Krakow, PL)
Thumbnail

6 speakers from this session

Mr Cesar Rios Navarro

Research Foundation Hospital of Valencia (INCLIVA), Valencia (Spain)
0 follower

Assistant Professor Yoku Kikuchi

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai (Japan)
0 follower

Doctor Jindrich Vainer

University Hospital Maastricht, Maastricht (Netherlands (The))
0 follower

Doctor Luigi Emilio Pastormerlo

High School Sant'Anna, Pisa (Italy)
0 follower

Associate Professor Alexandru Schiopu

Department of Clinical Sciences Malm?, Malm? (Sweden)
0 follower

Professor Piotr Musialek

Jagiellonian University, John Paul II Hospital, Dept of Cardiac & Vascular Diseases, Krakow (Poland)
5 presentations
1 follower

This platform is supported by

logo Novo Nordisk